VEEV:NYSE
Veeva Systems Inc
$285.58
arrow_upward
+0.73%(+2.08) 1D
Oct 7, 2:31:57 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VEEV...
Open
$284.23
High
$286.98
Low
$279.80
Mkt. cap
46.24B
Avg. vol.
1.76M
Volume
479.11K
P/E ratio
46.70
52-wk high
$308.36
52-wk low
$148.05
EPS
$6.11
Beta
0.93
Shares outstanding
161.91M
No. of employees
8K
Open
$284.23
High
$286.98
Low
$279.80
Mkt. cap
46.24B
Avg. vol.
1.76M
Volume
479.11K
P/E ratio
46.70
52-wk high
$308.36
52-wk low
$148.05
EPS
$6.11
Beta
0.93
Shares outstanding
161.91M
No. of employees
8K
News stories
From web sources and news partners
Zacks
·
4 hours ago
Veeva's DQS Scales Data Automation Across 1,000+ Clinical Studies
Yahoo! Finance Canada
·
5 hours ago
Veeva's DQS Scales Data Automation Across 1,000+ Clinical Studies
Investing.com Canada
·
6 hours ago
Veeva Systems reports over 175 biotechs using Basics platform By Investing.com
Stock Titan
·
1 day ago
Sites and sponsors saved thousands of hours on trial data cleanup with Veeva.
Profile
Veeva Systems Inc., headquartered in Pleasanton, California, provides cloud computing software, data, and consulting services for the life sciences industry. Its products are used to track all aspects of drug development and pharmaceutical manufacturing.
The company has 1,552 customers including Bayer, Boehringer Ingelheim, Eli Lilly and Company, Gilead Sciences, Merck & Co., Novartis, Alkermes plc, Alnylam Pharmaceuticals, bluebird bio, and Idorsia. Wikipedia
About Veeva Systems Inc
CEOPeter Gassner
Employees7.93K
Founded2007
HeadquartersPleasanton, California, United States
SectorHealth care
Websiteveeva.com